Cosmos Health, through its Subsidiary Cana Laboratories, Enters into an Advisory Agreement with the European Investment Bank (EIB) for the Financing of its €50M R&D Program; EIB Financing Represents up to 50%, or €25M, under the EIB’s Venture Debt Program
Advisory Agreement Secured: To advance the Company's EIB-backed R&D financing program€25 million potential financing opportunity: Up to 50% of the...